Evidence map›Paper›PMID 42018750›Full record

ArticleAmerican journal of hypertension2026

Evidence-informed prioritization of interventions for integrating hypertension management into cardiovascular-kidney-metabolic care in primary health care: HEARTS 2.0 Phase 3.

Pedro Ordunez, Andres Rosende, Maria Florencia Grande Ratti, Donald J DiPette, Ana Marcela Torres, Esteban Londoño, Sonia Y Angell, Mariana L Rodriguez de la Cerda, Norm R C Campbell, Libardo Rodríguez Martínez and 27 more

Abstract read
In one paragraph

Article in American journal of hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Pedro OrdunezDepartment of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0002-9871-6845
Andres RosendeDepartment of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0001-8173-0686
Maria Florencia Grande RattiDepartment of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0001-8622-8230
Donald J DiPetteDepartment of Internal Medicine. School of Medicine, University of South Carolina, Columbia, SC, United States.ORCID 0000-0002-5762-9104
Ana Marcela TorresScience and Knowledge for Impact Unit, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0003-0412-5540
Esteban LondoñoDepartment of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0003-3254-3651
Sonia Y AngellDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID 0000-0001-6031-910X
Mariana L Rodriguez de la CerdaDepartment of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0003-2759-0672
Norm R C CampbellDepartment of Medicine, University of Calgary, Calgary, Canada.ORCID 0000-0002-1093-4742
Libardo Rodríguez MartínezDepartment of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0001-7066-1208
Jeffrey BrettlerDepartment of Global Health, Kaiser Permanente Bernard J Tyson School of Medicine, Kaiser Permanente, CA, United States.ORCID 0000-0002-2069-9643
Fernando TortosaScience and Knowledge for Impact Unit, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0002-0303-6055
Vilma IrazolaDepartment of Research in Chronic Diseases, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.ORCID 0000-0002-6100-1862
Marc G JaffeDepartment of Global Health, Kaiser Permanente Bernard J Tyson School of Medicine, Kaiser Permanente, CA, United States.ORCID 0000-0002-5049-7815
Ariel IzcovichScience and Knowledge for Impact Unit, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0001-9053-4396
Niamh ChapmanSchool of Health Sciences, Faculty of Medicine and Health, the University of Sydney, Camperdown, Sydney, Australia.ORCID 0000-0001-6317-5594
Andelys de la RosaMinistry of Health, Santo Domingo, Dominican Republic.ORCID 0009-0000-6777-6055
Ana Claudia de SouzaDepartment of Neurology and Neurosurgery, Hospital Moinhos de Vento, Porto Alegre, Brazil.ORCID 0000-0002-8722-9988
Miguel Angel Diaz AguileraNational Center for Prevention and Disease Control (CENAPRECE) of the Mexican Ministry of Health, Mexico DF, Mexico.ORCID 0009-0008-4277-5855
Paula Diaz ValenciaEpidemiology Group, National School of Public Health, University of Antioquia, Medellin, Colombia.ORCID 0000-0001-8065-5629
David FloodDepartment of Medicine, University of MI, Ann Arbor, MI, United States.ORCID 0000-0002-4372-7387
Lourdes JarquinNoncommunicable Diseases Office, Ministry of Health, San Salvador, El Salvador.ORCID 0009-0001-6447-0103
Taskeen KhanWorld Innovation Summit for Health, Qatar Foundation, Doha, Qatar.ORCID 0000-0002-1676-4895
Javier MarianiCardiology Department, Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina.ORCID 0000-0002-9372-6817
Andrew E MoranResolve to Save Lives, Alexandria, VA, United States.ORCID 0000-0003-3554-0085
Carolina Neira OjedaDepartment of Noncommunicable Diseases, Ministry of Health of Chile, Santiago, Chile.ORCID 0000-0001-9133-8354
Emily RidleyPrisma Health, Columbia, SC, United States.ORCID 0000-0002-5043-1920
Marcela RiveraDivision of Primary Healthcare, Ministry of Health of Chile, Santiago, Chile.ORCID 0009-0007-7148-0768
Gonzalo RodriguezFavaloro Foundation, University Hospital, Buenos Aires, Argentina.ORCID 0000-0001-9915-2028
Cesar A RomeroRenal Division, Department of Medicine, Emory University-School of Medicine, Atlanta, GA, United States.ORCID 0000-0002-8445-9665
Santiago TorrobaCardiology Department, Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina.ORCID 0009-0006-6660-7325
Yamile Valdes GonzalezInstitute of Endocrinology, Public Health Ministry of Cuba, Havana, Cuba.ORCID 0000-0002-1437-7031
Natalia VensentiniNon-Communicable Disease Department, Ministry of Health, Buenos Aires, Argentina.ORCID 0009-0005-2059-4445
Irmgardt A WellmannResearch Center for Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala.ORCID 0000-0003-0184-5817
Eric ZunigaServicio de Salud Antofagasta, Universidad de Antofagasta, Antofagasta, Chile.ORCID 0000-0002-1136-8260
Ludovic ReveizScience and Knowledge for Impact Unit, Pan American Health Organization, Washington, DC, United States.ORCID 0000-0003-3186-9174
Paul K WheltonDepartment of Epidemiology, Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine, New Orleans, LA, United States.ORCID 0000-0002-2225-383X

Funding

Implementation research for comprehensive cardiometabolic care in GuatemalaK23HL161271 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Clifford Flood · 2022 to 2026
$949k
HEARTS in the Americas for Better Health Care for NCDs 607009NHLBI NIH HHS K23 HL161271NHLBI NIH HHS K23HL161271Resolve to Save Lives, Inc.
6 · The paper itself

Abstract

backgroundHEARTS in the Americas is the regional adaptation of the WHO Global HEARTS Initiative. This paper presents Phase 3 of HEARTS 2.0, an evidence-informed process to prioritize clinical and health-system interventions to support the operationalization of integrated cardiovascular, kidney, and metabolic (CKM) care in primary health care (PHC) and to inform the update of the HEARTS Clinical Pathway. CKM conditions frequently coexist, sharing common risk factors and pathophysiological mechanisms that exacerbate cardiovascular disease burden. Despite their overlap, clinical practice often remains siloed due to condition-specific guidelines, and its integration remains limited. To prioritize evidence-informed clinical and health-system interventions that support the operationalization of integrated CKM care within PHC and inform the update of the HEARTS Clinical Pathway.

methodsBuilding on previous phases of HEARTS 2.0, a multidisciplinary panel evaluated 45 candidate interventions in different areas. The selection process utilized structured evidence appraisal, Evidence-to-Decision frameworks, and a modified RAND/UCLA appropriateness method involving anonymized rating rounds.

resultsA total of 38 interventions were prioritized for implementation. Although hypertension management remains the primary entry point, the resulting framework integrates early detection of diabetes and chronic kidney disease, lifestyle interventions, risk-based combination pharmacotherapy, task-sharing, and longitudinal follow-up.

conclusionsBy translating dispersed guideline recommendations into implementable interventions, Phase 3 of HEARTS 2.0 provides an evidence-informed basis for advancing integrated CKM care at scale in PHC and guiding the forthcoming update of the HEARTS Clinical Pathway. The resulting framework offers a flexible, scalable approach for countries confronting similar epidemiological and health system challenges.

Indexed as

Delivery of Health Care, IntegratedEvidence-Based MedicineHypertensionPrimary Health CareHumansRisk Factorschronicdiabetes mellitusheart disease risk factorshypertensionprimary health carerenal insufficiency

Identifiers

PMID42018750
PMCPMC13369960

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.